SciBase Holding AB (FRA:5J3) Loans Receivable: €0.00 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:5J3 SciBase Holding AB FRA:5J3
61 GF Score
Price €1.64
GF Value €1.56
! 4 Warning Signs
View Full Analysis

What is SciBase Holding AB Loans Receivable?

SciBase Holding AB FRA:5J3 61 Loans Receivable is €0.00 Mil as of Jun. 2026. GuruFocus rates FRA:5J3 with a GF Score™ of 61/100 and a GF Value™ of €1.56. The stock has 4 warning signs investors should review.

SciBase Holding AB's Loans Receivable for the quarter that ended in Jun. 2026 was €0.00 Mil.

SciBase Holding AB Loans Receivable Related Terms

SciBase Holding AB Loans Receivable Historical Data

* Premium members only.

The historical data trend for SciBase Holding AB's Loans Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SciBase Holding AB Loans Receivable Chart

SciBase Holding AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Loans Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

SciBase Holding AB Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Loans Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
FRA:5J3
61GF Score
SciBase Holding AB FRA:5J3
Loans Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

SciBase Holding AB Loans Receivable Calculation

Loans Receivable are the funds that a company has lent but have not yet been repaid.

Frequently Asked Questions Learn more about Loans Receivable →
What does a Loans Receivable of €0.00 Mil mean?
SciBase Holding AB (FRA:5J3) has a Loans Receivable of €0.00 Mil as of Jun. 2026. Loans Receivable are the funds that a company has lent but have not yet been repaid. View historical data on SciBase Holding AB and its competitors.
Is SciBase Holding AB's Loans Receivable too high?
SciBase Holding AB's current Loans Receivable is €0.00 Mil. Overall, SciBase Holding AB has a GF Score™ of 61/100, reflecting its overall financial health beyond just this single metric.
How does SciBase Holding AB's Loans Receivable compare to ABT and SYK?
SciBase Holding AB's Loans Receivable of €0.00 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Loans Receivable for a Medical Devices & Instruments company?
A good Loans Receivable depends on the Medical Devices & Instruments industry context. However, Loans Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Loans Receivable mean?
A high Loans Receivable can signal that a stock is expensive relative to its fundamentals. Loans Receivable are the funds that a company has lent but have not yet been repaid. View historical data on SciBase Holding AB and its competitors. SciBase Holding AB's current Loans Receivable is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SciBase Holding AB stock overvalued right now?
SciBase Holding AB (FRA:5J3) has a current Loans Receivable of €0.00 Mil. The stock's GF Value™ is €1.56, compared to a current price of €1.64 — trading 5.1% above its estimated fair value. The current Loans Receivable is €0.00 Mil. SciBase Holding AB's overall GF Score™ is 61/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Loans Receivable calculated?
Loans Receivable is calculated from a company's financial statements. For SciBase Holding AB (FRA:5J3), the current Loans Receivable is €0.00 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is SciBase Holding AB (FRA:5J3) Overvalued in 2026?

Based on GuruFocus' analysis, SciBase Holding AB stock appears to be overvalued. The current stock price of €1.64 is trading 5.1% above its estimated GF Value™ of €1.56.

Key valuation signals for FRA:5J3:

  • Loans Receivable: €0.00 Mil
  • GF Value™: €1.56 vs. price of €1.64 (5.1% above fair value)
  • GF Score™: 61/100 with 4 warning signs

No single metric tells the full story. See the FRA:5J3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

SciBase Holding AB Business Description

Other Exchanges SCIB:Sweden
Address Landsvagen 39, Sundbyberg, Stockholm, SWE, 172 63
SciBase Holding AB is a medical technology company specializing in early detection of skin cancer and prevention in dermatology. SciBase develops, manufactures, and commercializes Nevisense, a point-of-care technology platform that combines AI (artificial intelligence) and EIS technology to elevate diagnostic accuracy and support the prevention of skin diseases. The company's product portfolio consists of the Nevisense platform technology for multiple clinical applications and proprietary Nevisense electrodes. The products are based on measurements using electrical impedance spectroscopy (EIS), analysed using custom artificial intelligence (AI)-based algorithms. The company operates in two segments, which include skin cancer and skin barrier assessment.
61GF Score

Get the complete analysis for FRA:5J3

Loans Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.64
Price
€1.56
GF Value